Targeting the Hepatic Stellate Cell Microenvironment: Nanomedicine Strategies for Liver Fibrosis Therapy

已完结 10 由 111 发布于 2026/8/11 17:29:00

DOI:10.1021/acs.molpharmaceut.5c01439
作者：Lulu Pei, , , Xing Du, , , Zehao Mao, , , Kai Ding, , , Jiangyu Li, , , Tianqing Liu*, , and , Yongmei Zhao*, 
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1021/acs.molpharmaceut.5c01439

American Chemical Society (ACS)

Abstract：Liver fibrosis, driven by hepatic stellate cells (HSCs) activation and pathological extracellular matrix (ECM) remodeling, involves dynamic crosstalk among macrophages, hepatocytes, liver si

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierInsight into the performance of valve-regulated lead-acid battery using sodium salt of poly(4-styrene sulfonic acid-co-maleic acid)-poly(vinyl alcohol) gel electrolyte